---
layout: post
title: "Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-05 18:58:00 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-27852
original_published: 2023-12-19 00:00:00 +0000
significance: 8.00
---

# Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** December 19, 2023 00:00 UTC
**Document Number:** 2023-27852

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices." FDA is issuing this draft guidance to clarify how FDA evaluates real- world data (RWD) to determine whether they are of sufficient quality for generating real-world evidence (RWE) that can be used in FDA regulatory decision-making for medical devices. This draft guidance proposes expanded recommendations to the 2017 guidance entitled "Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices." This draft guidance is not final nor is it for implementation at this time.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/12/19/2023-27852/use-of-real-world-evidence-to-support-regulatory-decision-making-for-medical-devices-draft-guidance)
- API: https://www.federalregister.gov/api/v1/documents/2023-27852

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
